About POC Blood Glucose Monitoring Devices POC blood glucose monitoring devices are portable, near-patient devices that allow the immediate detection of glucose levels in a patient and facilitate rapid treatment solutions if the need arises. These devices consist of minimum operator interaction and are non-invasive in nature with efficient data management and connectivity tools. The global POC blood glucose monitoring devices market is in its growing stage. A paradigm shift toward minimally invasive procedures for the screening of blood glucose level is increasing the demand for POC blood glucose monitoring devices in the market. Technavio’s analysts forecast the global POC blood glucose monitoring devices market to grow at a CAGR of 8.16% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global POC blood glucose monitoring devices market for 2017-2021. To calculate the market size, the report considers sales, volume, value of POC blood glucose monitoring devices. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report,... Research Beam Model: Research Beam Product ID: 2037711 3500 USD New
Global POC Blood Glucose Monitoring Devices Market 2017-2021
 
 

Global POC Blood Glucose Monitoring Devices Market 2017-2021

  • Category : Healthcare
  • Published On : September   2017
  • Pages : 90
  • Publisher : Technavio
 
 
 
About POC Blood Glucose Monitoring Devices

POC blood glucose monitoring devices are portable, near-patient devices that allow the immediate detection of glucose levels in a patient and facilitate rapid treatment solutions if the need arises. These devices consist of minimum operator interaction and are non-invasive in nature with efficient data management and connectivity tools. The global POC blood glucose monitoring devices market is in its growing stage. A paradigm shift toward minimally invasive procedures for the screening of blood glucose level is increasing the demand for POC blood glucose monitoring devices in the market.

Technavio’s analysts forecast the global POC blood glucose monitoring devices market to grow at a CAGR of 8.16% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global POC blood glucose monitoring devices market for 2017-2021. To calculate the market size, the report considers sales, volume, value of POC blood glucose monitoring devices.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global POC Blood Glucose Monitoring Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Alere
• F. Hoffmann-La Roche
• LifeScan

Other prominent vendors
• AgaMatrix
• Menarini Diagnostics
• Animas
• Ascensia Diabetes Care
• Bayer Healthcare
• BD
• BIOPTIK
• DarioHealth
• DexCom
• EKF Diagnostics
• GlySens
• HemoCue
• Integrity Applications
• International Biomedical
• Medisana
• MediWise
• Nemaura
• Nipro
• Nova Biomedical
• Omnis Health
• Owen Mumford
• Philips Healthcare
• Randox Laboratories
• Senseonics
• TaiDoc Technology

Market driver
• Availability of CGMS and SMBG systems for POC blood glucose monitoring
• For a full, detailed list, view our report

Market challenge
• High cost of diabetes management
• For a full, detailed list, view our report

Market trend
• Growing adoption of minimally invasive and technologically superior products
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Market overview
• Consumables
• Instruments
PART 07: Market segmentation by end-user
• Market overview
• Hospitals and clinics
• Clinical diagnostic laboratories
• Home care settings
PART 08: Geographical segmentation
• Market overview
• POC blood glucose monitoring devices market in Americas
• POC blood glucose monitoring devices market in EMEA
• POC blood glucose monitoring devices market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Growing adoption of minimally invasive and technologically superior products
• Increase in online marketing strategies
• Product bundling
PART 12: Vendor landscape
• Competitive landscape
PART 13: Key vendor analysis
• Alere
• F. Hoffmann-La Roche
• LifeScan
• Key companies to watch
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits?
Exhibit 01: Flow of market for POC blood glucose monitoring devices in 2016
Exhibit 02: Global POC blood glucose monitoring devices in 2016: Market highlights
Exhibit 03: Global POC blood glucose monitoring devices 2016-2021 ($ millions)
Exhibit 04: Global POC blood glucose monitoring devices market 2016: Market metric analysis
Exhibit 05: Five forces analysis
Exhibit 06: Global POC blood glucose monitoring devices market by product
Exhibit 07: Global POC blood glucose monitoring devices market by product: Overview
Exhibit 08: Technological advancements in global POC blood glucose monitoring devices market
Exhibit 09: Global POC blood glucose monitoring devices market by consumables 2016-2021 ($ millions)
Exhibit 10: Benefits of instruments
Exhibit 11: Global POC blood glucose monitoring devices market by instruments 2016-2021 ($ millions)
Exhibit 12: Advantages of different instruments
Exhibit 13: Global POC blood glucose monitoring devices market by end-user 2016 (% share)
Exhibit 14: Global POC blood glucose monitoring devices market by end-user 2016: Strategic analysis
Exhibit 15: Types of reference measurement services available in clinical diagnostic laboratories
Exhibit 16: Average cost of blood glucose testing in clinical diagnostic laboratories
Exhibit 17: Global POC blood glucose monitoring devices market 2016: Buying criteria analysis
Exhibit 18: Life cycle analysis of global POC blood glucose monitoring devices by geographies 2016
Exhibit 19: Global POC blood glucose monitoring devices market by geography 2016 and 2021 ($ millions)
Exhibit 20: Market overview of POC blood glucose monitoring devices in Americas
Exhibit 21: POC blood glucose monitoring devices market in Americas ($ millions)
Exhibit 22: Market overview of POC blood glucose monitoring devices market in EMEA
Exhibit 23: POC blood glucose monitoring devices market in EMEA ($ millions)
Exhibit 24: Market overview of POC blood glucose monitoring devices market in APAC
Exhibit 25: POC blood glucose monitoring devices market in APAC ($ millions)
Exhibit 26: Government programs to reduce cost burden for diabetics
Exhibit 27: Products recalled by POC blood glucose monitoring device manufacturers
Exhibit 28: Competitive structure analysis of global POC blood glucose monitoring devices market 2016
Exhibit 29: Market penetration of vendors in global POC blood glucose monitoring devices market 2016
Exhibit 30: Strategic success factors of companies in global POC blood glucose monitoring devices market 2016
Exhibit 31: Alere: Key highlights
Exhibit 32: Alere: Strength assessment
Exhibit 33: Alere: Strategy assessment
Exhibit 34: Alere: Opportunity assessment
Exhibit 35: F. Hoffmann-La Roche: Key highlights
Exhibit 36: F. Hoffmann-La Roche: Strength assessment
Exhibit 37: F. Hoffmann-La Roche: Strategy assessment
Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 39: LifeScan: Key highlights
Exhibit 40: LifeScan: Strength assessment
Exhibit 41: LifeScan: Strategy assessment
Exhibit 42: LifeScan: Opportunity assessment
Exhibit 43: Abbott: Company assessment
Exhibit 44: Siemens Healthineers: Company assessment

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT